Arcinova - A Quotient Sciences business

@Quotient_Sci is delighted to announce today the acquisition of Arcinova, the UK-based CDMO. Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

@Quotient_Sci announces that it has completed the rebrand of Arcinova. Now called Quotient Sciences – Alnwick, the site will play a key role in strengthening Quotient’s portfolio from candidate selection to commercial manufacturing. Read the release: quotientsciences.com/news/arcinova-…

An exciting milestone is approaching! On 1st July, Arcinova will become Quotient Sciences. Please make sure to follow Quotient Sciences on Twitter to stay up to date on all our latest news, services and capabilities.
Click here: x.com/Quotient_Sci

Keeping your #drugdevelopment on track is key, but what if you could accelerate drug development, cutting costs and time. This #webinar discusses #drugsubstance #manufacturing in early development and the benefits of #flowchemistry.

Register here: business-review-webinars.com/webinar/Pharma…

40+ years’ experience in providing #bioanalytical services across a spectrum of biological matrices, we can accelerate #drugdevelopment by cutting industry average lead times by 50%.
Integrated bioanalysis services support both small & large molecules.
arcinova.com/services/bioan…